Medicine access and procurement platform for Southeast Europe.
Improving access to essential medicines that are commercially neglected
One negotiation platform. Many independent hospitals and clinics.
Social Enterprise. We do not invest in traditional marketing or promotional activities. Instead, we channel those savings directly into healthcare systems by offering high-quality medicines at significantly lower prices. We reinvest 51% of our profits back into public healthcare.
Overlooked Therapies
Improving access to essential medicines that are commercially neglected.
AAP improves access to essential medicines that are globally available but locally unavailable or difficult to obtain in smaller Southeast European markets.
Many established, off-patent therapies are no longer actively supplied in smaller countries because of limited commercial potential, fragmented demand, or regulatory complexity. Yet these medicines may still have clear clinical value and support rational, cost-effective treatment.
AAP identifies such access gaps and works with qualified manufacturers, wholesalers, healthcare institutions, and professional stakeholders to create compliant supply solutions across the region.
Our focus is simple: proven medicines, clear clinical need, compliant access, and sustainable pricing.
Key activities
- Identifying essential medicines unavailable or underserved in Southeast Europe
- Sourcing established off-patent therapies from qualified manufacturers and wholesalers
- Creating compliant access pathways for non-registered or locally unavailable medicines
- Representing selected pharmaceutical manufacturers in regional markets
- Supporting rational, evidence-based pharmacotherapy through professional and scientific communication
Partner with us
AAP offers pharmaceutical manufacturers a regional access platform for Southeast Europe, particularly for established therapies that are commercially overlooked but medically relevant.
For healthcare partners, we provide a structured way to address medicine access gaps through compliant and quality-assured supply channels.
Contact us to explore cooperation.
Privacy Policy
Who we are
Article 1 — Scope
This privacy policy defines the rules related to the protection of individuals with regard to the processing of personal data and the rules related to the free movement of personal data, and in particular the obligations of the manager of personal data processing, the rights of data subjects, informing data subjects, the right to access data, the right to deletion, correction and limitation processing of personal data, the right to object, the right to data portability, the principles of personal data processing, supervision and other issues in accordance with the General Regulation on the Protection of Personal Data (hereinafter the Regulation), as well as other relevant legal norms in the Republic of Croatia.
Definitions
For the purposes of this Policy, the following terms have the meanings set out below:
- Personal data — all data relating to an identified or identifiable natural person;
- Processing — any operation performed on personal data, whether automated or not (collection, recording, organization, structuring, storage, adaptation, retrieval, use, disclosure, restriction, erasure, destruction, etc.);
- Controller — natural or legal person who determines the purposes and means of processing personal data;
- Processor — a natural or legal person who processes personal data on behalf of the controller;
- Recipient — a natural or legal person to whom personal data are disclosed, whether a third party or not;
- Consent — a voluntary, specific, informed and unambiguous indication of the data subject's wishes.
Consent
Consent is given by a clear affirmative action expressing the data subject’s voluntary, specific, informed and unambiguous agreement to the processing of personal data relating to them. Examples include ticking a box when visiting websites, selecting technical settings of information society services, or other clear affirmative actions. Silence, pre-ticked boxes or inactivity do not constitute consent. Special protections apply to children’s personal data.
Principles of processing
Personal data shall be processed lawfully, fairly and transparently. They shall be collected for specified, explicit and legitimate purposes and not further processed in a manner incompatible with those purposes. Data shall be adequate, relevant and limited to what is necessary for the purposes, accurate and kept up to date, stored only as long as necessary, and processed with appropriate security.
Lawfulness
Processing is lawful only if one of the following applies: (a) the data subject has given consent; (b) processing is necessary for the performance of a contract; (c) processing is necessary to comply with a legal obligation; (d) processing is necessary to protect vital interests; (e) processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority; or (f) processing is necessary for the purposes of legitimate interests pursued by the controller or a third party (where those interests are not overridden by the rights and freedoms of the data subject).
Rights of data subjects
Data subjects have the right to be informed, the right of access, the right to rectification, the right to erasure ('right to be forgotten'), the right to restriction of processing, the right to data portability, the right to object, and the right to withdraw consent at any time without affecting the lawfulness of processing based on consent before its withdrawal.
Responding to requests
The controller will act on requests from data subjects (access, correction, deletion, restriction, objection, portability, withdrawal of consent, and other requests) within one month of receipt; if not possible, the controller will inform the data subject within that period.
Automated decision-making
Data subjects have the right not to be subject to a decision based solely on automated processing, including profiling, producing legal effects concerning them or similarly significantly affecting them, unless specific exceptions apply (contract necessity, authorised by law, or explicit consent).
Records and security
Controllers must keep records of processing activities and implement appropriate technical and organisational measures to ensure the security of personal data, including protection against unauthorised or unlawful processing and against accidental loss, destruction or damage.
Data breaches and notifications
In the event of a personal data breach likely to result in a risk to the rights and freedoms of natural persons, the controller shall notify the supervisory authority without undue delay and, where feasible, within 72 hours of becoming aware of the breach. The controller shall document all breaches and measures taken in response.
Contact for exercising rights
Data subjects may submit requests or inquiries regarding their rights and data protection to the controller at: info@aap.hr
Access Adria Pharmaceuticals d.o.o.
Director: Luka Vončina
In Zagreb on September 23, 2025
Group Purchasing Organisation
Independent hospitals and polyclinics. Regional coverage. Procurement intelligence
Private healthcare in Southeast Europe has reached significant scale, but purchasing remains highly fragmented. By aggregating demand regionally, hospitals and polyclinics can improve purchasing conditions without losing independence.
The problem
- Individual hospitals and polyclinics negotiate from limited bargaining power
- Significant price differences for the same products from the same suppliers
- Suppliers prioritize public procurement and large hospital systems
- Individual clinics largely accept supplier-set terms
What the model enables
- Centralized negotiations with manufacturers and wholesalers
- Combined regional volumes across multiple countries
- Better prices and commercial conditions
- Better supplier attention and service levels
- Less operational complexity in procurement
- Access to regional equipment, leasing and financing programmes
"No exclusivity. No purchase obligation. No loss of clinical or operational independence. No complex ordering."
Contact us to explore cooperation.
Our Objectives
AAP focuses on the following key objectives.
Access Adria Pharmaceuticals is a social enterprise based in Zagreb, Croatia, dedicated to advancing public health across Southeastern Europe.
Enhanced access to overlooked therapeutic options
Expanding access to essential therapies that are often overlooked by the pharmaceutical industry — addressing critical unmet medical needs across Southeastern Europe.
Prevention of medication shortages
Ensuring a stable and reliable supply of essential medicines — preventing shortages and maintaining continuous access to vital treatments.
Improving health outcomes through cost efficiency
Providing cost-effective treatment alternatives that promote rational pharmacotherapy and improve patient outcomes, without undue financial strain on patients or health systems.
Regional purchasing power for independent providers
Helping hospitals, private clinics and medical centers achieve commercial terms previously available only to large hospital systems — without losing clinical or operational independence.
Reducing procurement fragmentation
Aggregating regional demand to deliver better prices, better supplier access, and greater negotiating power across Southeast Europe.
Smarter procurement. Better cost control.
Supporting hospitals and clinics with clearer purchasing benchmarks, category prioritization and framework terms that help control procurement costs, improve budget visibility and support sustainable growth.
"Universal health coverage can only be achieved when there is affordable access to safe, effective and quality medicines and health products."
— World Health OrganisationCore Operating Principles
AAP is dedicated to delivering long-term, sustainable value to patients, healthcare professionals, and healthcare systems.
Sustainability
Our social entrepreneurship model offers a sustainable and self-sufficient way to create impact — staying agile and building strong partnerships across the healthcare ecosystem.
Impact
We do not invest in traditional marketing or promotional activities. Instead, we channel those savings directly into healthcare systems by offering high-quality medicines at significantly lower prices.
Reinvestment
We reinvest 51% of our profits back into public healthcare — supporting initiatives that promote rational use of medicines, enhance clinical practice, and improve patient care.
Integrity
Our engagement with healthcare professionals is strictly educational and evidence-based — through scientific and professional channels, in full compliance with the highest ethical standards and principles of rational pharmacotherapy.
Contact
Contact AAP about medicine access, manufacturer cooperation, GPO membership, or healthcare procurement partnerships across Southeast Europe.
Get in touch
AAP handles enquiries related to medicine access, manufacturer cooperation, GPO membership, and regional healthcare procurement across Southeast Europe. Write to us directly and we will route your message to the right person.
info@aap.hrWe typically respond within one business day.
- Overlooked or unavailable medicines
- Manufacturer cooperation
- GPO membership for hospitals and clinics
- Medicine access gaps
- Healthcare procurement partnerships
- General enquiries
Company details
10000 Zagreb, Croatia